Sana Biotechnology SANA
NASDAQ SANA
$2.89 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Return on Equity [ROE] (2021 - 2026)

Updated

Sana Biotechnology (SANA) reported Return on Equity [ROE] of -159.78% for Q2 2026, down 4.05 percentage points from -155.73% a year earlier but up 17.50 percentage points from the prior quarter.

Analysis

Sana Biotechnology (SANA) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Sana Biotechnology posted Return on Equity [ROE] of -121.69%, down 20.31 percentage points from FY2024.

  • Return on Equity [ROE] has declined for three consecutive years, though with a four-year change of +109.94 percentage points (FY2021 to FY2025).
  • By year, Return on Equity [ROE] came in at -101.38% in FY2024 (-26.87 pp), -74.51% in FY2023 (-30.11 pp), -44.40% in FY2022 (+187.24 pp) and -231.63% in FY2021.
  • Five-year quarterly Return on Equity [ROE] spans a low of -177.28% in Q1 2026 and a high of -29.07% in Q1 2022.
  • Year over year, Return on Equity [ROE] has now declined in each of the last five quarters, with an average year-over-year change of -36.59 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q1 2022 (a gain of 159.14 percentage points); the low point was Q2 2025 (a drop of 84.97 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -177.28% (Q1 2026), -140.55% (Q4 2025) and -151.00% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Sana Biotechnology 864.99 Mn 864.99 Mn - -159.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -159.78%
Mar 31, 2026 -177.28%
Dec 31, 2025 -140.55%
Sep 30, 2025 -151.00%
Jun 30, 2025 -155.73%
Mar 31, 2025 -92.53%
Dec 31, 2024 -100.45%
Sep 30, 2024 -98.86%
Jun 30, 2024 -70.76%
Mar 31, 2024 -96.53%
Dec 31, 2023 -89.73%
Sep 30, 2023 -78.88%
Jun 30, 2023 -94.04%
Mar 31, 2023 -70.06%
Dec 31, 2022 -51.17%
Sep 30, 2022 -50.11%
Jun 30, 2022 -44.63%
Mar 31, 2022 -29.07%
Dec 31, 2021 -45.80%
Sep 30, 2021 -41.35%
API Access

Sana Biotechnology Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SANA&period=max&api_key=YOUR_API_KEY